The Oncology Institute to Participate in B. Riley Securities Institutional Investor Conference
The Oncology Institute (NASDAQ:TOI) announced that CEO Dr. Daniel Virnich and CFO Rob Carter will participate in the B. Riley Securities Institutional Investor Conference in Marina Del Rey, CA, on May 21, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
The Oncology Institute (NASDAQ:TOI) announced that CEO Dr. Daniel Virnich and CFO Rob Carter will participate in the B. Riley Securities Institutional Investor Conference in Marina Del Rey, CA, on May 21, 2026.
A fireside chat is scheduled from 9:00–9:40 a.m. PT and will be available via webcast on the company’s investor relations website.
Details
News Market Reaction – TOI
On May 13, the day this news came out, TOI closed 1.49% above the previous close. That session’s volume was 2.7x the stock’s average daily volume.
Data tracked by StockTitan Argus for the May 13 session.
Key Figures
- Fireside chat time
- 9:00–9:40 a.m. PT
- B. Riley Securities Institutional Investor Conference on May 21, 2026
- Q1 2026 revenue
- $147.4 million
- Quarter ended March 31, 2026
- Revenue growth
- 41.2%
- Q1 2026 year-over-year increase
- Q1 2026 gross profit
- $23.3 million
- Quarter ended March 31, 2026
- Gross profit growth
- 35.2%
- Q1 2026 year-over-year increase
- Q1 2026 net loss
- $2.5 million
- Narrowed from $19.6 million prior-year period
- Specialty pharmacy growth
- 78%
- Q1 2026 specialty pharmacy revenue increase
- Medicare savings
- $1.8 million
- CMS Enhancing Oncology Model Performance Period 3
Historical Context
-
Strong revenue growth and narrowed net loss for Q1 2026.
-
Announced Q1 2026 earnings release date and conference call details.
-
Reported $1.8M Medicare savings and improved per-episode performance.
-
Announced participation in Needham Healthcare Conference with a fireside chat.
-
Named a new Chief Legal Officer to oversee legal and compliance functions.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CERRITOS, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the B. Riley Securities Institutional Investor Conference, being held in Marina Del Rey, CA on Thursday, May 21, 2026, including a fireside chat from 9:00–9:40 a.m. PT.
A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.
____________________________
About The Oncology Institute (www.theoncologyinstitute.com):
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
ICR Healthcare
TOI@icrhealthcare.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.